ACCESS TO INSIGHT
|CORE FACULTY &
|CLINICAL RESEARCH GRANT||AWARDS||SCHOLARSHIP||RECIPIENTS||CONTACT US|
Access to Insight Awards Ceremony at the ISTH 2015
During ISTH 2015 in Toronto, Novo Nordisk took the opportunity to announce and congratulate the Access to Insight recipients from the last two years. Members of the Core Faculty and Review Board met the recipients at the Novo Nordisk Medical Exhibit and presented award certificates to the successful applicants.
The Basic Research Grant provides funding of €70,000 and is awarded for a 1-year project in basic science or translational research relevant to the understanding of the pathophysiology and treatment of haemostatic disorders.
In 2014 Mirko Pinotti from Ferrara, Italy and in 2015 Peter Lenting from Le Kremlin-Bicêtre, France received the grant for their research projects.
The Clinical Research Grant provides funding of €70,000 or €140,000 (for 1 to 2 years) and support of innovative haemostatic research on patient outcomes, quality of life, and social impacts.
Kevin Deschamps from Leuven, Belgium received this grant in 2014. In 2015 Víctor Jiménez-Yuste from Madrid, Spain will receive funding for his clinical research project.
In alternating years the Harold R. Roberts Award and the Ulla Hedner Award, each worth €15,000, are presented for excellent abstracts submitted to the WFH and ISTH conference, respectively.
In 2014 Lize van Vulpen from Utrecht, The Netherlands received the Harold R. Roberts Award, and Daniela Scalet from Ferrara, Italy was presented with the Ulla Hedner Award in 2015.
The fourth category of Novo Nordisk’s Access to Insight funding opportunities is the Training Scholarship. Successful applicants receive support for their training in haemophilia and other haemostatic disorders at a well-established, renowned haemophilia treatment centre. Funding for 6 or 12 months of training (€35,000 or €70,000) is available.
In 2014 Ana Lilia Hernandez-Moreno from Mexico City, Mexico and Mehran Karimi from Shiraz, Iran each received a training scholarship for 6 months. Scholarship recipients in 2015 were Oliver Grottke from Aachen, Germany and Giorgia Sacullo from Palermo, Italy.
Nigel Key, the chair of the Access to Insight Core Faculty, stressed that many high quality applications were submitted in the past years and highlighted that he is very happy with the choice of recipients, as he believes that all awards will promote excellent research and education in haemophilia and other bleeding disorders.
Novo Nordisk congratulates the recipients for their excellent work and would like to encourage health care professionals and researchers in the field to consider applying during the next Access to Insight funding cycle.
The Access to Insight Grants & Awards Core Faculty is pleased to announce Access to Insight – the Novo Nordisk Haemostasis Grants & Awards Initiative, which offers a series of exciting funding opportunities specially tailored to the needs of talented haemostasis physicians and researchers.
Novo Nordisk, a healthcare company with a leading position in haemostasis management, is strongly committed to supporting haemostasis research and education.
The initiative is steered by the Access to Insight Grant & Awards Core Faculty, a group of distinguished haemostasis experts chaired by Nigel Key, MB ChB, FRCP, from the University of North Carolina School of Medicine and the Harold R. Roberts Comprehensive Hemophilia Diagnostic and Treatment Center in Chapel Hill, NC, USA.
The Haemophilia Academy
is an independently run
training programme led
by a distinguished faculty
of haemophilia experts.